CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-05-15
著者
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
Tateno Masatoshi
Department of Pathology, Sapporo City General Hospital
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
NAGAI Hirokazu
Department of Clinical Research, Nagoya National Hospital
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Murate T
Nagoya University School Of Health Science
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
Murayama T
National Cancer Center Hospital Tokyo Jpn
-
Murayama Tohru
Hyogo Cancer Center Akashi Jpn
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
OGITA Masami
Sapporo National Hospital
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Taniwaki M
Kyoto Prefectural Univ. Medicine Kyoto
-
Takatoku Masaaki
Department Of Hematology And Oncology Kyoto Prefectural University Of Medicine
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
KAWASE Takakazu
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
OYAMA Takashi
Department of Medical Oncology, Aichi Cancer Center
-
HAMAZAKI Minoru
Department of Pathology, Shizuoka Children's Hospital
-
KAWASE Yoshiaki
Kitami Red Cross Hospital
-
MURAYAMA Toshihiko
Kumamoto National Hospital
-
MORI Yoshio
Nagoya National Hospital
-
NAOE Tomoki
First Department of Internal Medicine, Nagoya University School of Medicine
-
TAKAHASHI Toshitada
Division of Immunology, Aichi Cancer Center
-
Nakamura Shigeo
Department Of Pathology Nagoya University School Of Medicine
-
Takeuchi Takahiro
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takahashi Toshitada
愛知県がんセンター研究所 腫瘍免疫学
-
Taji Hirohumi
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Tateno Masatoshi
Department Of Pathology Asahikawa Medical College
-
Nagai Hirokazu
Nagoya Medical Center Nagoya Jpn
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kawase Takakazu
医学生物学研究所
-
Takenaka T
National Cancer Center Hospital Tokyo Jpn
-
Murayama T
Hematology/oncology Division
-
Takahashi Toshitada
Division Of Immunology Aichi Cancer Center
-
Tagawa Hiroyuki
Department Of Mathematical Sciences University Of Tokyo
-
Oyama Takashi
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Terauchi Takashi
Diagnostic Radiology Divisions National Cancer Center Hospital
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Taniguchi Hirokazu
Clinical Laboratory Division National Cancer Center Hospital
-
Nagai Hirokazu
Department Of Applied Chemistry Graduate School Of Engineering Osaka University
-
Oyama Takashi
Department Of Medical Oncology Aichi Cancer Center
-
Yano Kunio
県西部浜松医療センター
-
Hamazaki Minoru
Department Of Clinical Pathology Shizuoka Prefecture Children's Hospital
-
Hamazaki Minoru
Department Of Pathology Shizuoka Children's Hospital
-
Oyama Takashi
Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Takahashi Toshitada
Division Of Cancer Screening Research Center For Cancer Prevention And Screening National Cancer Cen
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Nakamura Shigeo
Department Of Cardiovascular Diseases. Kokura National Hospital
-
Tateno Masatoshi
Department Of Hematology Japanese Red-cross Nagasaki Atomic Bomb Hospital
-
NAKAMURA Shigeo
Department of Applied Chemistry, Faculty of Engineering, Kanagawa University
関連論文
- The Authors Reply: Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies
- Insomnia and Depression during Protective Isolation in Patients with Hematological Disorders
- Determination of Total Hydroperoxides in Oxidized Vegetable Oils Based on Triphenylphosphine Oxidation Using Electron Ionization Mass Spectrometry
- A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci.
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Increased Expression of Sucrase and Intestinal-type Alkaline Phosphatase in Human Gastric Carcinomas with Progression
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Castleman's Disease of the Retroperitoneum : With Special Reference to IgG4-Related Disorder
- Biological safety of water-soluble fullerenes evaluated using tests for genotoxicity, phototoxicity, and pro-oxidant activity
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Subsite (cervix/endometrium)-specific Risk and Protective Factors in Uterus Cancer
- Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
- Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
- Risk Factors of Thyroid Cancer among Women in Tokai, Japan
- Tobacco, Alcohol and Dietary Factors Associated with the Risk of Oral Cancer among Japanese
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Follicular lymphoma frequently originates in the salivary gland
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- "Follicular Variant" of Hyaline-vascular Type of Castleman's Disease : Histopathological and Immunohistochemical Study of 11 Cases
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- t(11 ; 18)(q21 ; q21)-Associated low-grade mucosa-associated lymphoid tissue lymphoma involving the gastrointestinal tract, the lung, and the salivary glands
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Transplantation of rat hepatic stem-like (HSL) cells with collagen matrices
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Genetic and functional variabilities in the human immuno @@S deficiency virus tyre 1 isolated from the same blood samples @@S ' with and without CD8+ cells
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- CD4^+ T-cells from peripheral blood of a patient with psoriasis recognize keratin 14 peptide but not 'homologous' streptococcal M-protein epitope
- Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
- Antiproliferative Effect of a Novel Cholecystokinin-B/Gastrin Receptor Antagonist, YM022
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Malignant Lymphoma and Tumor Suppressor Genes
- IgD monoclonal gammopathy of undetermined significance
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Current treatment strategy and new agents in mantle cell lymphoma
- Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II
- DNA-Binding Hemoproteins Tethering Polyamine Interface
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- In Vitro Effects of Recombinant Human IL-11 on Human Malignant Lymphoma Cells
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma